Skip to main content
Clinical Trials/NCT06306352
NCT06306352
Completed
N/A

The Effect of Vibrotactile Feedback on Exoskeleton Use in People With Motor Complete Spinal Cord Injury

Sint Maartenskliniek1 site in 1 country7 target enrollmentMarch 6, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Sint Maartenskliniek
Enrollment
7
Locations
1
Primary Endpoint
Walking distance covered
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims to investigate the impact of providing discrete vibrotactile feedback related to weight shift and step initiation on exoskeleton use in individuals with motor-complete SCI.

Detailed Description

Rationale: People with motor-complete spinal cord injury (SCI) lack motor function below the lesion level and are, thus, wheelchair-dependent. In recent years, wearable exoskeletons have emerged as potential mobility devices for this population. Although exoskeletons generate the basic motions for ambulation, postural stability must be maintained by the user. People with motor-complete SCI miss essential somatosensory perception, which affects their ability to maintain postural stability. Hence, walking in an exoskeleton is demanding, and crutches are necessary. When sensory information of a specific system is lost, the lack of sensory information can be substituted by providing feedback to another sensory system. As sensory feedback has been shown to improve postural control in people missing essential sensory information, such sensory substitution may also be effectively incorporated in people with complete SCI using an exoskeleton. Objective: The study aims to investigate the effect of vibrotactile feedback on exoskeleton use in people with motor-complete SCI. Study design: The proposed study is an experimental study. The study protocol includes six sessions of 90 minutes spread over three weeks. Sessions one to five are dedicated to training to assess the effect of vibrotactile feedback on exoskeleton motor learning. Session six is dedicated to evaluation to assess the effect of vibrotactile feedback on exoskeleton motor control.

Registry
clinicaltrials.gov
Start Date
March 6, 2023
End Date
June 21, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • SCI classification American Spinal Injury Association Impairment Scale (AIS) A or B
  • Minimally six months post-injury
  • Prior experience with the ReWalk Exoskeleton, able to walk independently

Exclusion Criteria

  • Pre-existing somatosensory problems before the SCI
  • Visual or auditory issues that are not resolved with glasses or a hearing device
  • Insufficient mastery of the Dutch language
  • Contraindications related to the ABLE Exoskeleton

Outcomes

Primary Outcomes

Walking distance covered

Time Frame: Up to 3 weeks

Walking distance covered during a 50-second walking trial.

Secondary Outcomes

  • User experience questionnaire(After 3 weeks)
  • Dutch version of the Quebec User Evaluation of Satisfaction with Assistive Technology (D-QUEST) - only including the eight items related to user satisfaction with the assistive device(After 3 weeks)
  • Reach path ratio(Up to 3 weeks)
  • Reach time(Up to 3 weeks)

Study Sites (1)

Loading locations...

Similar Trials